Evidence map›Paper›PMID 38802999›Full record

ArticleTechnology in cancer research & treatment

Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.

Dongxue Wang, Funing Yang, Guiping Han, Jifeng Zhang, Hongjia Wang, Zunyu Xiao, Weiyu Chen, Ping Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dongxue WangDepartment of Radiology and Nuclear Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID 0009-0000-9870-4759
Funing YangDepartment of Radiology and Nuclear Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Guiping HanDepartment of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jifeng ZhangDepartment of Radiology and Nuclear Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Hongjia WangDepartment of Radiology and Nuclear Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Zunyu XiaoDepartment of Nuclear Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Weiyu ChenDepartment of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
Ping LiDepartment of Radiology and Nuclear Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaBiomarkers, TumorColonic NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksTranscriptomeCell Line, TumorCell ProliferationComputational BiologyDatabases, GeneticHumansKaplan-Meier EstimateMalePrognosisBiomarkers, Tumorcolon adenocarcinomacuproptosisdihydrolipoamide S-acetyltransferasegene signatureprognostic model

Identifiers

PMID38802999
PMCPMC11135095

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.